These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
231 related items for PubMed ID: 1394038
1. The distribution of epithelial membrane antigen in thymic epithelial neoplasms. Fukai I, Masaoka A, Hashimoto T, Yamakawa Y, Mizuno T, Tanamura O. Cancer; 1992 Oct 15; 70(8):2077-81. PubMed ID: 1394038 [Abstract] [Full Text] [Related]
2. The MIC2 antibody 013. Practical application for the study of thymic epithelial tumors. Chan JK, Tsang WY, Seneviratne S, Pau MY. Am J Surg Pathol; 1995 Oct 15; 19(10):1115-23. PubMed ID: 7573670 [Abstract] [Full Text] [Related]
3. Thymic carcinoma arising in thymoma is associated with alterations in immunohistochemical profile. Kuo TT, Chan JK. Am J Surg Pathol; 1998 Dec 15; 22(12):1474-81. PubMed ID: 9850173 [Abstract] [Full Text] [Related]
4. Flow cytometric analysis of lymphoid cells in thymic epithelial neoplasms. Nakajima J, Takamoto S, Oka T, Tanaka M, Takeuchi E, Murakawa T. Eur J Cardiothorac Surg; 2000 Sep 15; 18(3):287-92. PubMed ID: 10973537 [Abstract] [Full Text] [Related]
5. Cytokeratins in normal thymus and thymic epithelial tumors. Fukai I, Masaoka A, Hashimoto T, Yamakawa Y, Mizuno T, Tanamura O. Cancer; 1993 Jan 01; 71(1):99-105. PubMed ID: 7677978 [Abstract] [Full Text] [Related]
6. Immunoreactivity of a new CD5 antibody with normal epithelium and malignant tumors including thymic carcinoma. Tateyama H, Eimoto T, Tada T, Hattori H, Murase T, Takino H. Am J Clin Pathol; 1999 Feb 01; 111(2):235-40. PubMed ID: 9930146 [Abstract] [Full Text] [Related]
7. Thymic carcinomas, but not thymomas and carcinomas of other sites, show CD5 immunoreactivity. Dorfman DM, Shahsafaei A, Chan JK. Am J Surg Pathol; 1997 Aug 01; 21(8):936-40. PubMed ID: 9255257 [Abstract] [Full Text] [Related]
8. An immunohistochemical study of thymic epithelial tumors. I. Epithelial component. Kodama T, Watanabe S, Sato Y, Shimosato Y, Miyazawa N. Am J Surg Pathol; 1986 Jan 01; 10(1):26-33. PubMed ID: 2420219 [Abstract] [Full Text] [Related]
9. Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma. Pan CC, Chen PC, Chou TY, Chiang H. Hum Pathol; 2003 Nov 01; 34(11):1155-62. PubMed ID: 14652817 [Abstract] [Full Text] [Related]
10. Intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) exhibits CD5 immunoreactivity: new evidence for thymic differentiation. Dorfman DM, Shahsafaei A, Miyauchi A. Histopathology; 1998 Feb 01; 32(2):104-9. PubMed ID: 9543665 [Abstract] [Full Text] [Related]
12. Neuroendocrine differentiation in thymic epithelial tumors with special reference to thymic carcinoma and atypical thymoma. Hishima T, Fukayama M, Hayashi Y, Fujii T, Arai K, Shiozawa Y, Funata N, Koike M. Hum Pathol; 1998 Apr 01; 29(4):330-8. PubMed ID: 9563781 [Abstract] [Full Text] [Related]
17. Immunohistochemical differential diagnosis between thymic carcinoma and type B3 thymoma: diagnostic utility of hypoxic marker, GLUT-1, in thymic epithelial neoplasms. Kojika M, Ishii G, Yoshida J, Nishimura M, Hishida T, Ota SJ, Murata Y, Nagai K, Ochiai A. Mod Pathol; 2009 Oct 01; 22(10):1341-50. PubMed ID: 19648882 [Abstract] [Full Text] [Related]
18. Degree of malignancy of thymic epithelial tumors in terms of nuclear DNA content and nuclear area. An analysis of 39 cases. Asamura H, Nakajima T, Mukai K, Noguchi M, Shimosato Y. Am J Pathol; 1988 Dec 01; 133(3):615-22. PubMed ID: 3202120 [Abstract] [Full Text] [Related]